Adaptimmune Therapeutics PLC (ADAPY) stock
ADAPYOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2025, quý kết thúc ngày Jun 30, 2025Last filing: 10-Q on Aug 13, 2025Score 3/30
$0.04+0.00 (+9.38%)
Close on Oct 19, 2026Market cap $55.46MP/E –Yield –
Adaptimmune Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Adaptimmune Therapeutics's total debt was $25.68M at Jun 30, 2025. For fiscal 2024 it was $50.24M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $50.24M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $25.68M | +2.9% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $25.41M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $50.24M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $49.87M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $24.95M | – |
See a number that looks wrong?